scholarly journals Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape

Immunity ◽  
2021 ◽  
Vol 54 (8) ◽  
pp. 1901
Author(s):  
Frédéric Mourcin ◽  
Léa Verdiére ◽  
David Roulois ◽  
Rada Amin ◽  
Claire Lamaison ◽  
...  
Immunity ◽  
2021 ◽  
Author(s):  
Frédéric Mourcin ◽  
Léa Verdière ◽  
David Roulois ◽  
Rada Amin ◽  
Claire Lamaison ◽  
...  

2012 ◽  
Vol 3 ◽  
Author(s):  
Frédéric Mourcin ◽  
Céline Pangault ◽  
Rada Amin-Ali ◽  
Patricia Amé-Thomas ◽  
Karin Tarte

Blood ◽  
2021 ◽  
Author(s):  
Erwan Dumontet ◽  
Celine Pangault ◽  
David Roulois ◽  
Matthis Desoteux ◽  
Simon Léonard ◽  
...  

Follicular Lymphoma (FL) originates in the lymph nodes (LN) and infiltrates bone marrow (BM) early in the course of the disease. BM FL B cells are characterized by a lower cytological grade, a decreased proliferation, and a specific phenotypic and subclonal profile. Mesenchymal stromal cells (MSC) obtained from FL BM display a specific gene expression profile (GEP), including enrichment for a lymphoid-stromal cell signature, and an increased capacity to sustain FL B-cell growth. However, the mechanisms triggering the formation of the medullar FL permissive stromal niche have not been yet identified. In the current work, we demonstrated that FL B cells produced extracellular vesicles (EVs) that could be internalized by BM-MSC, making them more efficient to support FL B-cell survival and quiescence. Accordingly, EVs purified from FL BM plasma activated TGF-b dependent and independent pathways in BM-MSC, modified their GEP, triggering an upregulation of factors classically associated with hematopoietic stem cell niche, including CXCL12 or angiopoietin-1. Moreover, we provided the first characterization of BM FL B-cell GEP, allowing the definition of the landscape of molecular interactions they could engage with EV-primed BM-MSC. This work identified FL-derived EVs as putative mediators of BM stroma polarization and supported further investigation of their clinical interest for targeting the crosstalk between BM-MSC and malignant B cells.


1966 ◽  
Vol 93 (2) ◽  
pp. 177-183 ◽  
Author(s):  
J. Kwittken
Keyword(s):  

2001 ◽  
Vol 66 (2) ◽  
pp. 100-106 ◽  
Author(s):  
M. Bellido ◽  
E. Rubiol ◽  
J. Ubeda ◽  
O. Lopez ◽  
C. Estivill ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document